CBT Pharmaceuticals, Inc.

Release Summary

CBT Pharmaceuticals presented preclinical data at AACR on CBT-101 demonstrating its selectivity, safety, and efficacy in suppressing tumor growth.

CBT Pharmaceuticals, Inc.